Prevention of atherothrombotic events in adult patients with research hub

A randomized, open-label, single dose, 2-way crossover bioequivalence study comparing ticagrelor 90 mg hard capsules (PG402 [Celon Pharma]) vs ticagrelor 90 mg film-coated tablets (Brilique [AstraZeneca AB]) under fasting conditions in healthy volunteers

This study compares a new capsule version of ticagrelor with the existing tablet. We want to see if both work the same way in healthy adults. Ticagrelor helps prevent serious heart problems like heart attacks.